This Company Has Our Hearts – Steven Morris – BIOLIFE4D
- Author
- Richard Jacobs
- Published
- Tue 22 Oct 2019
- Episode Link
- https://pdcn.co/e/dts.podtrac.com/redirect.mp3/traffic.libsyn.com/secure/findinggeniuspodcast/1571736416731-2053805039e5a46efb1a302e12113ac8.mp3
BIOLIFE4D is back to tell us more about the technology they are using to create a bioengineered heart! In the United States, there are about 200,000 people who could use a heart transplant to save their lives, but only about 3,500 heart transplants take place each year.
This discrepancy is due to a lack of viable donor hearts. BIOLIFE4D is addressing this problem by developing the technology to create a heart out of the cells of the very patient who will receive the heart for transplantation. Listen in to hear Steven Morris, CEO, and president of BIOLIFE4D, explain how such a heart can be made, why such a method reduces rejection risk, and how it can improve accuracy and ethics in drug testing.
Learn more at www.BIOLIFE4D.com.
